CRK7 modifies the MAPK pathway and influences the response to endocrine therapy. Read more about CRK7 modifies the MAPK pathway and influences the response to endocrine therapy.
BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Read more about BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.
Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Read more about Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma.
Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Read more about Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans.
Impaired repair of cyclobutane pyrimidine dimers in human keratinocytes deficient in p53 and p63. Read more about Impaired repair of cyclobutane pyrimidine dimers in human keratinocytes deficient in p53 and p63.
Trans-fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant. Read more about Trans-fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant.
Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells. Read more about Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells.
Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. Read more about Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk.
BRCA1 and BRCA2 as ovarian cancer susceptibility genes. Read more about BRCA1 and BRCA2 as ovarian cancer susceptibility genes.
Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells. Read more about Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells.
